ASHP Spearheads Effort to Push for Congressional Action on Compounding

8/5/2013

Nine groups, including provider organizations, health care facilities, and patient advocacy groups, offered their support for bipartisan legislation in the Senate to address sterile compounding, an effort organized by ASHP.

In a letter sent to the sponsors of the “Pharmaceutical Quality, Security, and Accountability Act of 2013”  (S. 959),  the groups expressed support for the creation of a new category of registration with the Food and Drug Administration (FDA) for commercial compounding outsourcers. The groups noted that the legislation “adequately reflects recent shifts in the pharmaceutical marketplace” and thanked the committee for recognizing the role that traditional compounding pharmacies play in patient care by keeping traditional pharmacy compounding under the purview of state boards of pharmacy. 

The letter was signed by ASHP, the American College of Clinical Pharmacy, the American Society for Parenteral and Enteral Nutrition, Cleveland Clinic, theHealthcare Supply Chain Association, Johns Hopkins Medicine, Novation, the PewCharitable Trusts, and Premier.

ASHP members can show support for the legislation by sending an email asking their two senators to vote “yes” on the legislation. Check out the Compounding “Take Action” page to learn more about how S. 959 will protect patients. 

 quoted from here